Immusant entered the industry of Commercial Medical Research in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417110, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Leslie J Williams by calling (617) 229-5761 during business hours. You can also write to the business’ Single Location at 1 Kendall Square # B2003, Cambridge, Massachusetts MA 02139. You can also visit the company’s website at immusant.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Immusant |
| Representative: | Leslie J Williams |
| Place of Business: | 1 Kendall Square # B2003, Cambridge, MA 02139 |
| Contact Number: | (617) 229-5761 |
| Website: | immusant.com |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 5417110 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2010 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Immusant is a company operating from Middlesex, Massachusetts providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2010 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 5417110 as Commercial Medical Research.
With a current employee count of 1 to 4, Immusant has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Leslie J Williams at (617) 229-5761 for related queries, or to locate its Single Location using the coordinates 42.3631,-71.1033.
The Single Location can also be found at the street address 1 Kendall Square # B2003 in Cambridge, Massachusetts 02139 and can be engaged online through the company website at immusant.com, the company Twitter , and Facebook page .